Heart Failure-USB: Prediction and Progression
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients hospitalized with a primary diagnosis of ACS
• Patients hospitalized with a primary or secondary diagnosis of AHF
Locations
Other Locations
Switzerland
Cardiology, University Hospital Basel
RECRUITING
Basel
Contact Information
Primary
Christian Müller, Prof. Dr.
Christian.mueller@usb.ch
0041 6132 86 549
Backup
Fiona Nafaa, MD
fiona.nafaa@usb.ch
+41 61 32 87747
Time Frame
Start Date: 2019-06-13
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 6000
Treatments
acute coronary syndrome (ACS)
Outcome information (all-cause death, heart failure (HF) hospitalizations) of patients hospitalized with a primary diagnosis of ACS is analyzed.
acute heart failure (AHF)
Outcome information (all-cause death, heart failure (HF) hospitalizations) of patients hospitalized with a primary or secondary diagnosis of AHF is analyzed.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Basel, Switzerland